Key Findings
Propelled by factors like the low performance of branded drugs as compared to generic drugs and rising spending on healthcare and research, the global drug discovery market is expected to make a leap of 9.73% CAGR, increasing its revenue from $ 36.7 billion to $83.6 billion between the forecast years of 2018-2026.
Market Insights
Technology-wise, the global drug discovery market is segmented into Protein Microarrays, QPCR, Mass Spectrometry, DNA Microarrays, High Throughput Screening, Protein and Nucleic Acid Isolation, Gel Electrophoresis, Chromatography, and Other Technologies. Extensive R&D for new product launches can be viewed as major opportunities for the market to expand.
Regional Insights
North America, Asia-Pacific, Europe and Rest of World are the geographical segments of this market. By the end of the forecast period, the North American market is anticipated to account for the lion's share of the global market. The U.S is expected to be a major contributor to this region, driven by high healthcare spending and growing lifestyle oriented diseases. Also, the Asia-Pacific market is predicted to register the fastest growth driven by high investments and growing R&D.
Competitive Insights
Noted players in the global drug discovery market include Bayer Ag, AstraZeneca Plc, Boehringer Ingelheim, F. Hoffmann-La Roche Ltd, Eli Lily, GlaxoSmithKline Llc, Merck & Co. Inc, Sanofi and Pfizer Inc.
Global Drug Discovery Market Forecast 2018-2026
Table of Contents
1. Research Scope
1.1. Study Goals
1.2. Scope of The Market Study
1.3. Who Will Find This Report Useful?
1.4. Study And Forecasting Years
2. Research Methodology
2.1. Sources of Data
2.1.1. Secondary Data
2.1.2. Primary Data
2.2. Top Down Approach
2.3. Bottom-Up Approach
2.4. Data Triangulation
3. Executive Summary
3.1. Market Summary
3.2. Key Findings
3.2.1. High Prevalence Rates of Major Health Disorders
3.2.2. North America Has The Highest Market Share
3.2.3. Asia Pacific Is The Fastest Growing Region
3.2.4. Implementation of Drug Discovery Programs
4. Market Determinants
4.1. Market Drivers
4.1.1. Aging Population
4.1.2. Branded Drugs Are Outperforming Due To High Cost As Compared To Generic Drugs
4.1.3. Spending On Healthcare Has Been Increasing
4.1.4. Global Increase In Lifestyle Oriented Diseases & Fatalities
4.2. Market Restraints
4.2.1. Government Regulations Delaying The Processes
4.2.2. Delay In Product Launches
4.2.3. Poor Access To The Healthcare Services In Developing Markets
4.2.4. Market Is Shifting From Branded To Generic Drugs
4.3. Market Challenges
4.3.1. Cost Barrier For Local People In Emerging Economies
4.4. Market Opportunities
4.4.1. Extensive R&D For New Product Launches
5. Market Segmentation
5.1. Market By Technology 2018-2026
5.1.1. Qpcr
5.1.2. Dna Microarrays
5.1.3. Protein Microarrays
5.1.4. High-Throughput Screening
5.1.5. Mass Spectrometry
5.1.6. Gel Electrophoresis
5.1.7. Chromatography
5.1.8. Protein And Nucleic Acid Isolation
5.1.9. Other Technologies
6. Key Analytics
6.1. Porter's Five Forces Analysis
6.1.1. Threats of New Entrants(Low)
6.1.2. Competitive Rivalry (High)
6.1.3. Bargaining Power of Buyers (Medium)
6.1.4. Bargaining Power of Suppliers (Low)
6.1.5. Threat of Substitute Products (High)
6.2. Value Chain Analysis
6.3. Key Excerpts of The Study
6.3.1. Relaxation In The Regulations By The Government Which Stops Researchers From Doing Research.
6.3.2. Market Leaders Should Open Up Their Branches And Research Labs In Emerging Markets.
6.4. Pestle Analysis
6.5. Opportunity Matrix
7. Geographical Analysis
7.1. North America
7.1.1. United States (U.S.)
7.1.2. Canada
7.2. Europe
7.2.1. United Kingdom (Uk)
7.2.2. France
7.2.3. Germany
7.2.4. Spain
7.2.5. Italy
7.2.6. Rest of Europe (Roe)
7.3. Asia Pacific
7.3.1. India
7.3.2. China
7.3.3. Japan
7.3.4. Korea
7.3.5. Australia
7.3.6. Rest of Asia-Pacific (Roapac)
7.4. Rest of The World (Row)
8. Company Profiles
8.1. Astrazeneca Plc
8.1.1. Company Overview
8.1.2. Product Portfolio
8.1.3. Swot Analysis
8.1.4. Strategic Initiatives
8.2. Bayer Ag
8.2.1. Company Overview
8.2.2. Product Portfolio
8.2.3. Swot Analysis
8.2.4. Strategic Initiatives
8.3. Boehringer Ingelheim
8.3.1. Company Overview
8.3.2. Product Portfolio
8.3.3. Swot Analysis
8.4. Eli Lily
8.4.1. Company Overview
8.4.2. Product Portfolio
8.4.3. Swot Analysis
8.4.4. Strategic Initiatives
8.5. F. Hoffmann-La Roche Ltd
8.5.1. Company Overview
8.5.2. Product Portfolio
8.5.3. Swot Analysis
8.5.4. Strategic Initiatives
8.6. Glaxosmithkline Llc
8.6.1. Company Overview
8.6.2. Product Portfolio
8.6.3. Swot Analysis
8.6.4. Strategic Initiatives
8.7. Johnson And Johnson
8.7.1. Company Overview
8.7.2. Product Portfolio
8.7.3. Swot Analysis
8.7.4. Strategic Initiatives
8.8. Merck & Co. Inc.
8.8.1. Company Overview
8.8.2. Product Portfolio
8.8.3. Swot Analysis
8.8.4. Strategic Initiatives
8.9. Pfizer, Inc.
8.9.1. Company Overview
8.9.2. Swot Analysis
8.9.3. Strategic Initiatives
8.10. Sanofi
8.10.1. Company Overview
8.10.2. Product Portfolio
8.10.3. Swot Analysis
8.10.4. Strategic Initiatives
List of Tables
Table 1 Global Drug Discovery Market By Geography 2018-2026 (In $Million)
Table 2 Fact Sheets of Global Fatalities
Table 3 Global Drug Discovery Market, By Technology, 2018-2026
Table 4 Global Drug Discovery Market In Qpcr By Geography 2018-2026 (In $Million)
Table 5 Global Drug Discovery Market In Dna Microarrays By Geography 2018-2026 (In $Million)
Table 6 Global Drug Discovery Market In Protein Microarrays, By Geography 2018-2026(In $Million)
Table 7 Global Drug Discovery Market In High Throughput Screening, By Geography 2018-2026(In $Million)
Table 8 Global Drug Discovery Market In Mass Spectrometry, By Geography 2018-2026 (In $Million)
Table 9 Global Drug Discovery Market In Gel Electrophoresis, By Geography 2018-2026, (In $Million)
Table 10 Global Drug Discovery Market In Chromatography, By Geography 2018-2026 (In $Million)
Table 11 Global Drug Discovery Market In Protein And Nucleic Acid Isolation, By Geography 2018-2026 (In $Million)
Table 12 Global Drug Discovery Market In Other Technologies Market, By Geography 2018-2026 (In $Million)
Table 13 Global Drug Discovery Market, By Geography 2018-2026 (In $Million)
Table 14 North America Drug Discovery Market, 2018-2026 (In $ Million)
Table 15 Europe Drug Discovery Market, 2018-2026 (In $Million)
Table 16 Asia-Pacific Drug Discovery Market, 2018-2026 (In $Million)
List of Figures
Figure 1 Global Drug Discovery Market 2018-2026 (In $Million)
Figure 2 Global Drug Discovery Market In Qpcr 2018-2026 (In $Million)
Figure 3 Global Drug Discovery Market In Dna Microarrays 2018-2026 (In $Million)
Figure 4 Global Drug Discovery Market In Protein Microarrays 2018-2026 (In $Million)
Figure 5 Global Drug Discovery Market In High Throughput Screening 2018-2026 (In $Million)
Figure 6 Global Drug Discovery Market In Mass Spectrometry 2018-2026 (In $Million)
Figure 7 Global Drug Discovery Market In Gel Electrophoresis 2018-2026 (In $Million)
Figure 8 Global Drug Discovery Market In Chromatography 2018-2026 (In $Million)
Figure 9 Global Drug Discovery Market In Protein And Nucleic Acid Isolation 2018-2026 (In $Million)
Figure 10 Global Drug Discovery Market In Other Technologies 2018-2026 (In $Million)
Figure 11 Global Drug Discovery Market, By Geography 2018-2026 (In $Million)
Figure 12 North America Drug Discovery Market, 2018-2026 (In $ Million)
Figure 13 United States Drug Discovery Market, 2018-2026 (In $ Million)
Figure 14 Canada Drug Discovery Market, 2018-2026 (In $Million)
Figure 15 Europe Drug Discovery Market, 2018-2026 (In $Million)
Figure 16 United Kingdom Drug Discovery Market, 2018-2026 (In $Million)
Figure 17 France Drug Discovery Market, 2018-2026 (In $Million)
Figure 18 German Drug Discovery Market, 2018-2026 (In $Million)
Figure 19 Spain Drug Discovery Market, 2018-2026 (In $Million)
Figure 20 Italy Drug Discovery Market, 2018-2026 (In $Million)
Figure 21 Rest of Europe (Roe) Drug Discovery Market, 2018-2026 (In $Million)
Figure 22 Asia-Pacific Drug Discovery Market, 2018-2026 (In $Million)
Figure 23 India Drug Discovery Market, 2018-2026 (In $Million)
Figure 24 China Drug Discovery Market, 2018-2026 (In $Million)
Figure 25 Japan Drug Discovery Market, 2018-2026 (In $Million)
Figure 26 Korea Drug Discovery Market, 2018-2026 (In $Million)
Figure 27 Australia Drug Discovery Market, 2018-2026 (In $Million)
Figure 28 Rest of Asia-Pacific (Roapac) Drug Discovery Market, 2018-2026 (In $Million)
Figure 29 Rest of The World (Row) Drug Discovery Market, 2018-2026 (In $Million)
Global High Content Screening Market Research Report 2024 (Status and Outlook)
Published: 15-Dec-2023 Price: US 3200 Onwards Pages: 124
Report Overview:
High-content screening (HCS) or high-content analysis (HCA) (also known as cellomics), is a set of analytical techniques that is applied in genetic research and drug discovery processes in order to recognize elements such as peptides, small molecules, or genetic materials (such as RNAi) that have the potential to modify the phenotype of a cell in a certain manner. High-content screening employs a set of analytical procedures such as multi-parameter image processing, automa......
Global Fragment-Based Drug Discovery Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 07-Dec-2023 Price: US 3380 Onwards Pages: 108
Market Overview of Global Fragment-Based Drug Discovery market:
According to our latest research, the global Fragment-Based Drug Discovery market looks promising in the next 5 years. As of 2022, the global Fragment-Based Drug Discovery market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysi......
Global High Throughput Screening Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 28-Nov-2023 Price: US 3380 Onwards Pages: 111
Market Overview of Global High Throughput Screening market:
According to our latest research, the global High Throughput Screening market looks promising in the next 5 years. As of 2022, the global High Throughput Screening market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
High throughput screening refers to the experimental method based on molecular and cellular levels, using microplate......
Global High Content Screening Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 09-Nov-2023 Price: US 3380 Onwards Pages: 111
Market Overview of Global High Content Screening market:
According to our latest research, the global High Content Screening market looks promising in the next 5 years. As of 2022, the global High Content Screening market was estimated at USD 579.78 million, and it's anticipated to reach USD 1216.18 million in 2028, with a CAGR of 13.14% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the ......
Global Botanical and Plant Derived Drugs Market Insights, Forecast to 2029
Published: 14-Aug-2023 Price: US 4900 Onwards Pages: 88
Botanical drugs are those drugs which are derived from medicinal plants. Plant derived drugs are combination of botanical as well as other approved drugs that contains plant materials, synthetic and semi synthetic substances. Botanical drugs consist of vegetable material, algae and macroscopic fungi. They are used in treatment of various diseases, such as central nervous system disorders, cardiovascular diseases, infectious diseases and respiratory diseases. Botanical drugs are available in vari......
Global High Content Screening Market Insights, Forecast to 2029
Published: 11-Aug-2023 Price: US 4900 Onwards Pages: 110
High-content screening (HCS) or high-content analysis (HCA) (also known as cellomics), is a set of analytical techniques that is applied in genetic research and drug discovery processes in order to recognize elements such as peptides, small molecules, or genetic materials (such as RNAi) that have the potential to modify the phenotype of a cell in a certain manner. High-content screening employs a set of analytical procedures such as multi-parameter image processing, automated microscopy, fluores......
Global High Throughput Screening Market Insights: Impact of COVID-19 and Future Expectations to 2028
Published: 27-Jun-2023 Price: US 3260 Onwards Pages: 115
High throughput screening refers to the experimental method based on molecular and cellular levels, using microplate as an experimental tool carrier, performing the test process with an automated operating system, collecting experimental results data with sensitive and rapid detection instruments, and processing experiments with computer analysis. Data, testing tens of millions of samples at the same time, and supporting the running technical system with the corresponding database, it is charact......
Global Fragment-based Drug Discovery Market Insights, Forecast to 2029
Published: 31-May-2023 Price: US 4900 Onwards Pages: 111
The introduction of new techniques into the existing fragment-based drug discovery practices have created significant reductions in time and cost, driving the demand for such practices.
Market Analysis and Insights: Global Fragment-based Drug Discovery Market
The global Fragment-based Drug Discovery market is projected to grow from US$ 365.8 million in 2023 to US$ 533.8 million by 2029, at a Compound Annual Growth Rate (CAGR) of 6.5% during the forecast period.
The US & Cana......
High Throughput Screening Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030
Published: 05-May-2023 Price: US 4150 Onwards Pages: 146
The study predicts the short term and long term trends that can shape up the future of the High Throughput Screening market including the COVID-19 pandemic implications for High Throughput Screenings industry. The report presents market size forecasts across types, applications, end users and countries across regions. Strategic imperatives for development managers, decision makers and industry professionals including market trends, drivers, challenges, five forces analysis, insights on markets a......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
